Selectquote, Inc. current report, 03 November 2022

Full document

SelectQuote, Inc. Form 8-K Summary

Business Context and Reporting Period

SelectQuote, Inc. furnished this Form 8-K on November 3, 2022, under Item 2.02 to report financial results for the first quarter ended September 30, 2022. The filing references an accompanying press release and investor presentation, but their substantive contents are not included in the provided filing text.

Financial Performance and Liquidity

  • Revenue, profit or loss, cash flow, margins, debt, liquidity, and other financial metrics: the filing text does not provide clear values.
  • Comparative-period results and detailed operating performance: not provided in the filing text.

Material Changes Versus the Prior Comparable Period

The filing does not provide sufficient financial data to identify quantified changes versus the prior comparable period. Investors should review Exhibits 99.1 and 99.2 for the reported results and comparisons.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

  • The filing states that the Company notified the New York Stock Exchange of its intent to cure a stock-price deficiency and may have plans for doing so.
  • Forward-looking statements are subject to risks including the Company’s ability to regain compliance with applicable NYSE continued-listing standards within the cure period and to maintain compliance thereafter.
  • The filing refers investors to the risk factors in the Company’s Form 10-K for the year ended June 30, 2022 and subsequent SEC filings.
  • The press release and investor presentation were furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act, except as expressly incorporated by reference.

Important Facts for Investors to Verify

  1. Review Exhibit 99.1 for first-quarter revenue, earnings, cash flow, balance-sheet, and outlook details.
  2. Review Exhibit 99.2 for management’s presentation of operating trends, key metrics, and guidance.
  3. Verify the nature, cure period, and status of the NYSE stock-price deficiency and any subsequent listing compliance updates.
  4. Assess the risk factors in the June 30, 2022 Form 10-K and later SEC filings, particularly those concerning NYSE compliance and operating performance.